Bioequivalency Study of CM082 Tablet in Healthy Volunteers

Clinical trial NCT04328506 · COMPLETED

Trial details

NCT number: NCT04328506
Sponsor: AnewPharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2020-06-01
Primary completion: 2020-07-27
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.